摘要
目的:构建带有Myc标签的Thr-213、Thr-235、Ser-404磷酸化位点突变为Ala的Tau蛋白真核表达质粒,并在真核细胞中表达Myc-Tau3m蛋白。方法:利用重组PCR方法得到Thr-213、Thr-235、Ser-404磷酸化位点突变为Ala的编码序列,将其插入经Bam HⅠ和KpnⅠ酶切的p XJ40-Myc表达载体,在人293T细胞中转入空载体和重组质粒,利用Western印迹检测其表达及功能。结果:测序和酶切结果证实Myc-Tau3m真核表达质粒构建成功,转染293T细胞后获得表达,表达产物可促进微管的乙酰化。结论:构建了Thr-213、Thr-235、Ser-404磷酸化位点突变的Myc-Tau3m真核表达载体,为进一步研究Tau蛋白磷酸化的生理机能奠定了基础。
Objective: To construct the human Tau(T231A, S235A, S404A) mutation and detect its function in regulating microtubules acetylation. Methods: The human Tau(T231A, 5235A, S404A) mutation was obtained by recombinant PCR and cloned into pXJ40-Myc vector. The recombinant plasmid was transfected into 293T cells, and the expression of Myc-Tau3m and mierotubules acetylation was detected by Western blot. Results: Myc- Tau3m eukaryotie expression vector labeled with Mye tag was successfully constructed. The inserted fragment was confirmed by sequencing. Myc-Tau3m was expressed in 293T cells and enhanced the acetylation of microtubules. Conclusion: The eukaryotic expression vector of Myc-Tau3m was successfully constructed and expressed in 293T cells.
出处
《生物技术通讯》
CAS
2016年第1期44-47,共4页
Letters in Biotechnology
基金
国家自然科学基金(81372161
31470773
81272231)